+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Brain Tumor Therapeutics Market by Product Type (Devices, Pharmaceutical), Therapeutic Approach (Chemotherapy, Immunotherapy, Radiotherapy), Tumor Type, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Brain Tumor Therapeutics Market by Product Type (Devices, Pharmaceutical), Therapeutic Approach (Chemotherapy, Immunotherapy, Radiotherapy), Tumor Type, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Brain Tumor Therapeutics Market by Product Type (Devices, Pharmaceutical), Therapeutic Approach (Chemotherapy, Immunotherapy, Radiotherapy), Tumor Type, End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011114
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The brain tumor therapeutics market is advancing quickly, shaped by scientific innovation, regulatory evolution, and fresh clinical paradigms. Senior leaders seeking robust market insights will benefit from a detailed analysis of therapeutic advancements, competitive shifts, and evolving supply chain dynamics.

Market Snapshot: Brain Tumor Therapeutics Market

The brain tumor therapeutics market demonstrated measurable growth from 2024 to 2025 and is forecast to sustain a strong compound annual growth rate through 2030. Continued investment in genetics, data analytics, and sophisticated drug-delivery systems means decision-makers must monitor both innovation cycles and regional trends to remain competitive.

Scope & Segmentation

This research provides a detailed breakdown across product segments, emerging technologies, therapeutic approaches, end users, and regional landscapes:

  • Product Types: Diagnostic imaging equipment, radiation equipment, surgical instruments, targeted pharmaceutical compounds
  • Therapeutic Approaches: Chemotherapy (alkylating agents, antimetabolites, plant alkaloids), immunotherapy (CAR T, checkpoint inhibitors, vaccines), radiotherapy (brachytherapy, external beam, stereotactic radiosurgery), surgical techniques (craniotomy, stereotactic surgery)
  • Tumor Types: Astrocytoma, glioblastoma, meningioma
  • End Users: Ambulatory surgical centers, hospitals, specialty clinics
  • Distribution Channels: Hospital, online, and retail pharmacies
  • Regions: Americas (US – including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada, Mexico, Brazil, Argentina); Europe, Middle East, and Africa (including UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland); Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Leading Companies: Merck & Co., F. Hoffmann-La Roche, Novocure, Bristol-Myers Squibb, Pfizer, AbbVie, AstraZeneca, Novartis, Teva Pharmaceutical, GlaxoSmithKline

Key Takeaways for Senior Decision-Makers

  • Genetic profiling and molecular diagnostics are now central to precision treatment planning, changing the foundational approach to brain tumor therapy.
  • Innovative device technologies, such as AI-enabled imaging and minimally invasive tools, are supporting improved diagnosis and safer surgical intervention.
  • Digital pathology and machine learning are accelerating diagnostic workflows, enabling clinicians to tailor patient care more efficiently.
  • Collaborative partnerships between academia, biotech, and pharma are compressing R&D timelines, particularly in novel modalities like oncolytic viruses and mRNA therapeutics.
  • Regional disparities suggest advanced market adoption in North America, while Asia-Pacific and select EMEA areas present opportunities for expansion and localized strategies.
  • Integrated solutions—combining therapeutics, devices, and digital health—are becoming key to competitive differentiation.

Tariff Impact on the Brain Tumor Therapeutics Market

Recent US trade policy changes have led to tariff increases affecting imported medical devices and pharmaceutical inputs. As a result, manufacturers are reassessing supply chain strategies, exploring in-country production, and revisiting procurement partnerships to manage potential cost pressures and supply continuity risks. This environment is encouraging investments in regional manufacturing hubs and adaptive procurement processes.

Methodology & Data Sources

The research combines primary interviews with experts in neuro-oncology, regulatory affairs, engineering, and pharmaceuticals, alongside extensive review of peer-reviewed journals, conference proceedings, and regulatory databases. Cross-referencing clinical trials and patent registries with advanced analytics enabled robust scenario modeling and validated trend identification.

Why This Report Matters

  • Enables leaders to align innovation and operational strategies with sophisticated scientific and regulatory trends in brain tumor therapeutics.
  • Prepares organizations to respond to evolving regional opportunities, supply chain complexities, and new collaborative care models.
  • Strengthens strategic planning with actionable intelligence drawn from expert interviews and well-validated secondary research.

Conclusion

This report offers executives targeted guidance to anticipate market shifts, seize innovation-driven opportunities, and ensure resilience in the fast-evolving brain tumor therapeutics market. Stakeholders gain a clear, actionable cross-section of current and emerging dynamics, supporting well-informed, forward-looking decisions.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increased adoption of personalized vaccine therapies targeting tumor-specific antigens
5.2. Emergence of multi-modal treatment regimens combining immunotherapy and targeted agents
5.3. Advancements in blood-based liquid biopsy assays for early detection of brain tumor recurrence
5.4. Rising investment in CAR T-cell therapies for aggressive and recurrent glioblastoma cases
5.5. Integration of AI-powered imaging analytics to improve tumor segmentation and treatment planning
5.6. Development of blood-brain barrier penetrating small molecules for diffuse intrinsic pontine glioma
5.7. Growing emphasis on patient-reported outcomes to guide neurocognitive sparing treatment strategies
5.8. Strategic collaborations between biotech pioneers and academic centers for novel glioma target discovery
5.9. Regulatory approvals accelerating availability of oncolytic virus therapies for high-grade gliomas
5.10. Investment in adaptive clinical trial designs to accelerate brain tumor therapeutic evaluations
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Brain Tumor Therapeutics Market, by Product Type
8.1. Introduction
8.2. Devices
8.2.1. Imaging Equipment
8.2.2. Radiation Equipment
8.2.3. Surgical Instruments
8.3. Pharmaceutical
9. Brain Tumor Therapeutics Market, by Therapeutic Approach
9.1. Introduction
9.2. Chemotherapy
9.2.1. Alkylating Agents
9.2.2. Antimetabolites
9.2.3. Plant Alkaloids
9.3. Immunotherapy
9.3.1. CAR T
9.3.2. Checkpoint Inhibitors
9.3.3. Vaccines
9.4. Radiotherapy
9.4.1. Brachytherapy
9.4.2. External Beam Radiotherapy
9.4.3. Stereotactic Radiosurgery
9.5. Surgery
9.5.1. Craniotomy
9.5.2. Stereotactic Surgery
10. Brain Tumor Therapeutics Market, by Tumor Type
10.1. Introduction
10.2. Astrocytoma
10.3. Glioblastoma
10.4. Meningioma
11. Brain Tumor Therapeutics Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Hospitals
11.4. Specialty Clinics
12. Brain Tumor Therapeutics Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacies
12.3. Online Pharmacies
12.4. Retail Pharmacies
13. Americas Brain Tumor Therapeutics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Brain Tumor Therapeutics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Brain Tumor Therapeutics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Merck & Co., Inc.
16.3.2. F. Hoffmann-La Roche Ltd.
16.3.3. Novocure Ltd.
16.3.4. Bristol-Myers Squibb Company
16.3.5. Pfizer Inc.
16.3.6. AbbVie Inc.
16.3.7. AstraZeneca plc
16.3.8. Novartis AG
16.3.9. Teva Pharmaceutical Industries Ltd.
16.3.10. GlaxoSmithKline plc
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BRAIN TUMOR THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BRAIN TUMOR THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BRAIN TUMOR THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. BRAIN TUMOR THERAPEUTICS MARKET: RESEARCHAI
FIGURE 26. BRAIN TUMOR THERAPEUTICS MARKET: RESEARCHSTATISTICS
FIGURE 27. BRAIN TUMOR THERAPEUTICS MARKET: RESEARCHCONTACTS
FIGURE 28. BRAIN TUMOR THERAPEUTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BRAIN TUMOR THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMAGING EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMAGING EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIATION EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIATION EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY ALKYLATING AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY ALKYLATING AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY ANTIMETABOLITES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY ANTIMETABOLITES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PLANT ALKALOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PLANT ALKALOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CAR T, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CAR T, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHECKPOINT INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHECKPOINT INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CRANIOTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CRANIOTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY STEREOTACTIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY STEREOTACTIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY ASTROCYTOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY ASTROCYTOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY GLIOBLASTOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY GLIOBLASTOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY MENINGIOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY MENINGIOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 131. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 134. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 135. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2024 (USD MILLION)
TABLE 136. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2025-2030 (USD MILLION)
TABLE 137. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 138. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 139. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 140. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 141. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 142. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 143. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 144. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 145. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 146. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 147. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. CANADA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 154. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 155. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2024 (USD MILLION)
TABLE 156. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2025-2030 (USD MILLION)
TABLE 157. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 158. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 159. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 160. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 161. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 162. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 163. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 164. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 165. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 166. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 167. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. MEXICO BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 254. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 255. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 256. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 257. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2024 (USD MILLION)
TABLE 258. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2025-2030 (USD MILLION)
TABLE 259. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 260. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 261. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 262. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 263. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 264. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 265. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 266. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 267. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 268. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 269. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. GERMANY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 276. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 277. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2024 (USD MILLION)
TABLE 278. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2025-2030 (USD MILLION)
TABLE 279. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 280. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 281. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 282. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 283. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 284. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 285. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 286. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 287. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 288. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 289. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. FRANCE BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. ITALY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 314. ITALY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 315. ITALY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 316. ITALY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 317. ITALY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2024 (USD MILLION)
TABLE 318. ITALY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPROACH, 2025-2030 (USD MILLION)
TABLE 319. ITALY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 320. ITALY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 321. ITALY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 322. ITALY BRAIN TUMOR THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 323. ITALY BRAIN TUMOR THERAPEUTICS M

Samples

Loading
LOADING...

Companies Mentioned

  • Merck & Co., Inc.
  • F. Hoffmann-La Roche Ltd.
  • Novocure Ltd.
  • Bristol-Myers Squibb Company
  • Pfizer Inc.
  • AbbVie Inc.
  • AstraZeneca plc
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • GlaxoSmithKline plc

Table Information

Report AttributeDetails
No. of Pages182
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.56 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.28 Billion
Compound Annual Growth Rate8.2%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Brain Tumor Therapeutics - Global Strategic Business Report - Product Image

Brain Tumor Therapeutics - Global Strategic Business Report

  • Report
  • 182 Pages
  • Global
From
2025 Global Forecast for Brain Tumor Therapeutics Market (2026-2031 Outlook)-High Tech Outlook Report - Product Image

2025 Global Forecast for Brain Tumor Therapeutics Market (2026-2031 Outlook)-High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
Brain Tumor Diagnosis & Treatment Market by Treatment Type (Chemotherapy, Immunotherapy, Radiotherapy), Diagnosis Type (Biopsy, Imaging, Molecular Diagnostics), End User, Tumor Type - Global Forecast 2025-2030 - Product Image

Brain Tumor Diagnosis & Treatment Market by Treatment Type (Chemotherapy, Immunotherapy, Radiotherapy), Diagnosis Type (Biopsy, Imaging, Molecular Diagnostics), End User, Tumor Type - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Brain Tumor Diagnosis & Therapeutics Market by Therapeutic Modality, Imaging Technology, End User, Tumor Type, Tumor Grade, Patient Age Group - Global Forecast 2025-2030 - Product Image

Brain Tumor Diagnosis & Therapeutics Market by Therapeutic Modality, Imaging Technology, End User, Tumor Type, Tumor Grade, Patient Age Group - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Brain Tumor Diagnosis and Therapeutics Market Size, Share & Trends Analysis Report by Type (Primary, Secondary), Product, Diagnosis (MRI, CT, PET-CT), Therapeutics, End Use, and Region with Growth Forecasts, 2025-2030 - Product Image

Brain Tumor Diagnosis and Therapeutics Market Size, Share & Trends Analysis Report by Type (Primary, Secondary), Product, Diagnosis (MRI, CT, PET-CT), Therapeutics, End Use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.